Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotransplant(BTRN) -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (144)	11/29/1998 5:58:00 PM
From: Pseudo Biologist	Read Replies (1) \| Respond to of 1475

Rick, about those CD antigens. The second link claims to have been updated a few months ago; the first one does look pretty dated. ncbi.nlm.nih.gov ( Modified 06/22/98 prow@ncbi.nlm.nih.gov ) The last item is CD166. Isn't there a committee or something that meets (once a year? every two?) to assign these names to relevant molecules characterized since the last one? Sounds almost like electing a new pope, white smoke and all -g-, if this is how it works, which I may be imagining. This is an interesting link re. CD nomenclature and swines (as in BTRN's mini-swines -g-): nadc.ars.usda.gov More seriously, thanks for the review and insights on Sachs, XenoMune, AlloMune, etc. PB